3M products align with current best practice standards.

의료 관련 공인기관에서는 BSI를 줄일 수 있는 최선의 방법이 무엇인지에 대한 조사가 계속되고 있습니다.  
3M™은 이 기관들에서 공표한 표준 지침에 부합하는 제품군을 제공하고 있습니다.

Guideline

guideline_05

CDC 2017

Centers for Disease Control: Guidelines for the Prevention of Intravascular Catheter-Related Infections(2017 Updated)¹

For patients aged 18 years and older: a. Chlorhexidine-impregnated dressings with an FDA-cleared label that specifies a clinical indication for reducing catheter-related bloodstream infection(CRBSI) or catheter associated blood stream infection(CABSI) are recommended to protect the insertion site of short-term, non-tunneled central venous catheters. Category IA Use a sutureless securement device to reduce the risk of infection for intravascular catheters. Category II

Checklist for prevention of central line-associated bloodstream infections(2017)

  • Handle and maintain central lines appropriately: For patients 18 years of age or older, use a chlorhexidine impregnated dressing with an FDA cleared label that specifies a clinical indication for reducing CLABSI for short-term non-tunneled catheters unless the facility is demonstrating success at preventing CLABSI with baseline prevention practices.
  • Supplemental strategies for consideration: Antiseptic impregnated caps for access ports.
guideline_06

INS 2016

INS Infusion Therapy Standards of Practice(2016)²

Standard 34: Use of passive disinfecting caps containing disinfecting agent(IPA) shown to reduce intraluminal microbial contamination and reduce rates of CLABSIs. Use of disinfection caps on peripheral catheters has limited evidence but should be considered.

Standard 37: Consider the use of an engineered stabilization device(ESD*) to stabilize and secure Vascular Access Devices(VADs). Inadequate stabilization and securement can cause unintentional dislodgement and complications requiring premature VAD removal. Sutures are associated with needle stick injury, in addition to supporting the growth of biofilm and increasing the risk of catheter-related bloodstream infection.

Standard 41: Use chlorhexidine-impregnated dressings over CVADs to reduce infection risk when extraluminal route is primary source of infection.

guideline_07

SHEA 2014

Society for Healthcare Epidemiology of America(SHEA) Strategies to Prevent CLABSI in Acute Care Hospitals(2014)³

Use chlorhexidine-containing dressings for CVCs in patients over 2 months of age
(quality of evidence: I).
Use an antiseptic-containing hub/connector cap/port protector to cover connectors
(quality of evidence: I).

Reference

  1. O’Grady NP, Alexander, M., Burns, L.A., et al., the Healthcare Infection Control Practices Advisory Committee (HICPAC) Guidelines for the prevention of intravascular catheter-related infections, 2011. 2017 update.

  2. Gorski L, Hadaway L, Hagle ME, McGoldrick M, Orr M, Doellman D. Infusion Therapy Standards of Practice. J Infus Nurs. 2016;39(suppl 1): S1-S59.

  3. Marschall J, Mermel LA, Fakih M, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. 2014 update. Infect Control Hosp Epidemiol. 2014;35(7):753-771.
logo_01

법적정보  |  개인정보처리방침
3M 2020. All Rights Reserved

서울특별시 영등포구 의사당대로 82, 19층
사업자등록번호: 116-81-06399
대표전화: 080-033-4114

이 제품은 ‘의료기기’이며, ‘사용상의 주의사항’과 ‘사용방법’을 잘 읽고 사용하십시오.

항균성 창상 피복재 (Tegaderm CHG)
심의번호 : 2020-I10-21-1986
비이식형혈관접속용기구 (Curos)
심의번호 : 2020-I10-21-1987